Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055367
Status:
COMPLETED
Last Update Posted:
2016-06-16
First Post:
2003-02-26
Brief Title:
Safety Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohns Disease
Sponsor:
Biogen
Organization:
Biogen
Organization Data
Organization:
Biogen
Class:
INDUSTRY
Study ID:
CD305
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Biogen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Elan Pharmaceuticals | INDUSTRY |